|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.46 CHF | +1.05% |
|
+5.21% | +15.38% |
| 02-14 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
| 02-13 | Sector Update: Health Care Stocks Higher Friday Afternoon | MT |
| Capitalization | 311B 262B 239B 228B 423B 28,211B 439B 2,778B 1,104B 13,581B 1,165B 1,141B 47,688B | P/E ratio 2026 * |
21.5x | P/E ratio 2027 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise value | 344B 290B 264B 252B 468B 31,190B 486B 3,072B 1,221B 15,015B 1,288B 1,262B 52,725B | EV / Sales 2026 * |
6x | EV / Sales 2027 * | 5.65x |
| Free-Float |
87.19% | Yield 2026 * |
2.7% | Yield 2027 * | 2.78% |
Last Transcript: Novartis AG
| 1 day | +0.54% | ||
| 1 week | +5.21% | ||
| Current month | +10.33% | ||
| 1 month | +9.39% | ||
| 3 months | +19.55% | ||
| 6 months | +26.18% | ||
| Current year | +15.38% |
| 1 week | 119.8 |  | 126.46 |
| 1 month | 112.74 | | 126.46 |
| Current year | 107.68 | | 126.46 |
| 1 year | 81.1 | | 126.46 |
| 3 years | 73.74 | | 126.46 |
| 5 years | 72.84 | | 126.46 |
| 10 years | 65.09 | | 126.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
| Director of Finance/CFO | 61 | 24/04/2013 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 10.4% | 121 M€ | |
| -0.11% | 5.57% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.05% | +5.21% | +32.09% | +59.35% | 311B | |
| +0.17% | -1.72% | +23.18% | +210.44% | 929B | |
| -0.45% | +1.44% | +55.91% | +52.76% | 587B | |
| +1.76% | +3.61% | +20.03% | +53.25% | 409B | |
| +0.39% | +2.15% | +22.80% | +31.27% | 374B | |
| +0.28% | +9.16% | +29.42% | +33.43% | 320B | |
| +1.82% | -0.43% | +46.26% | +12.75% | 301B | |
| -0.95% | -1.08% | -45.97% | -36.53% | 219B | |
| +0.82% | -3.94% | +26.80% | +53.79% | 199B | |
| +2.09% | +1.63% | +48.90% | +82.22% | 192B | |
| Average | +0.55% | +1.82% | +25.94% | +55.27% | 384.1B | |
| Weighted average by Cap. | +0.42% | +1.37% | +28.39% | +81.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.27B 48.31B 44.07B 42.01B 78.06B 5,200B 80.98B 512B 204B 2,503B 215B 210B 8,790B | 59.73B 50.39B 45.97B 43.82B 81.41B 5,424B 84.46B 534B 212B 2,611B 224B 219B 9,168B |
| Net income | 14.51B 12.24B 11.16B 10.64B 19.77B 1,317B 20.51B 130B 51.55B 634B 54.4B 53.28B 2,226B | 15.9B 13.41B 12.23B 11.66B 21.67B 1,443B 22.48B 142B 56.5B 695B 59.62B 58.4B 2,440B |
| Net Debt | 32.81B 27.68B 25.25B 24.07B 44.72B 2,979B 46.4B 293B 117B 1,434B 123B 121B 5,036B | 26.66B 22.49B 20.51B 19.56B 36.33B 2,421B 37.7B 238B 94.75B 1,165B 99.98B 97.92B 4,092B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/02/26 | 126.46 CHF | +1.05% | 2,832,774 |
| 13/02/26 | 125.14 CHF | +1.08% | 4,755,788 |
| 12/02/26 | 123.80 CHF | +0.57% | 3,348,098 |
| 11/02/26 | 123.10 CHF | +1.74% | 4,177,152 |
| 10/02/26 | 121.00 CHF | +0.67% | 3,106,255 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition